Li CL, Zhao JQ, Zang B.
PRKAA1 rs13361707 C/T polymorphism confers decreased susceptibility to esophageal cancer: A case-control study.
J Clin Lab Anal 2020;
34:e23406. [PMID:
32488984 PMCID:
PMC7521242 DOI:
10.1002/jcla.23406]
[Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/29/2020] [Revised: 04/28/2020] [Accepted: 05/05/2020] [Indexed: 12/18/2022] Open
Abstract
Background
Several studies probed into the connection between esophageal cancer (EC) risk and PRKAA1 rs13361707 C/T
polymorphism, but obtained insignificant findings.
Methods
In this study, 814 EC cases and 961
controls from Eastern China were recruited to validate the relationship between this polymorphism and EC susceptibility.
Results
Data suggested rs13361707 C/T
polymorphism in PRKAA1 gene was significantly related with a lower risk for EC. Such significant connection was also uncovered in subgroups of males, smokers, drinkers and individuals with age ≥ 60 years. In addition, this polymorphism
was linked with the pathological grading, distant metastasis, and histology of EC.
Conclusion
In summary, PRKAA1 rs13361707 C/T
polymorphism is related to the risk and clinical properties of EC patients in East China.
Collapse